# Beyond the basics: rethinking antimicrobial stewardship by targeting cytomegalovirus immune globulin for immunocompromised patients

## TL;DR

This paper explores improving antimicrobial stewardship by focusing on cytomegalovirus immune globulin use in immunocompromised patients.

## Contribution

The study introduces a drug restriction program to enhance appropriate use of CMV-IGIV in immunocompromised patients.

## Key findings

- A drug restriction program increased appropriate use of CMV-IGIV.
- Targeting CMV-IGIV therapy shows potential as a stewardship strategy.
- Immunocompromised patients benefit from improved antimicrobial stewardship approaches.

## Abstract

Identifying actionable stewardship targets in immunocompromised patients is challenging due to limited data and high morbidity. One approach could be targeting therapy with limited evidence, like cytomegalovirus immune globulin (CMV-IGIV). We implemented a drug restriction program that increased appropriate use of CMV-IGIV, highlighting a unique stewardship opportunity in immunocompromised populations.